Sabby Management, LLC 13F holdings, Q2 2025
Holdings as of June 30, 2025 · filings on SEC EDGAR · latest filing →
Sabby Management, LLC disclosed 33 US equity positions worth $13.0m in its Q2 2025 13F filing. The largest position was TEMPEST THERAPEUTICS INC at 14.5% of the reported book, followed by EOSE and LYRA THERAPEUTICS INC. Against the Q1 2025 filing, it opened 24 new positions, added to 0 and reduced 8 among the top 33 holdings.
What did Sabby Management, LLC own in Q2 2025? Top 33 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2025 |
|---|---|---|---|---|---|---|---|
| 1 | TEMPEST THERAPEUTICS INC | 14.5% | $1.9m | 276,587 | – | new | |
| 2 | EOSE EOS ENERGY ENTERPRISES INC | Industrials | 13.5% | $1.8m | 342,303 | -50% | reduced |
| 3 | LYRA THERAPEUTICS INC | 8.7% | $1.1m | 125,729 | – | new | |
| 4 | LEXX LEXARIA BIOSCIENCE CORP | 7.8% | $1.0m | 1,165,144 | – | new | |
| 5 | CAN-FITE BIOPHARMA LTD | 6.3% | $818.7k | 779,744 | – | new | |
| 6 | IMNN IMUNON INC | 5.5% | $720.0k | 900,000 | – | new | |
| 7 | BTBT BIT DIGITAL INC | 5.0% | $646.0k | 295,000 | -37% | reduced | |
| 8 | BRIACELL THERAPEUTICS CORP | 4.9% | $634.7k | 598,743 | – | new | |
| 9 | SAFE & GREEN HOLDINGS CORP | 3.5% | $450.7k | 702,000 | – | new | |
| 10 | IWM ISHARES TR | 3.3% | $432.4k | 2,004 | -91% | reduced | |
| 11 | ITERUM THERAPEUTICS PLC | 3.3% | $428.6k | 430,761 | – | new | |
| 12 | XTI AEROSPACE INC | 3.1% | $399.0k | 244,780 | -24% | reduced | |
| 13 | SUNE SUNATION ENERGY INC | 2.8% | $358.2k | 226,710 | – | new | |
| 14 | CHANSON INTL HOLDINGS | 2.2% | $283.1k | 2,185,933 | – | new | |
| 15 | POLYRIZON LTD | 1.9% | $251.6k | 340,464 | – | new | |
| 16 | SNOW LAKE RESOURCE LTD | 1.8% | $228.2k | 63,044 | – | new | |
| 17 | AKTX AKARI THERAPEUTICS PLC | 1.6% | $210.3k | 179,785 | – | new | |
| 18 | DIGITAL ALLY INC | 1.4% | $186.2k | 78,245 | – | new | |
| 19 | BJDX BLUEJAY DIAGNOSTICS INC | 1.3% | $165.2k | 96,033 | – | new | |
| 20 | AIRE REALPHA TECH CORP | 1.2% | $159.9k | 523,449 | – | new | |
| 21 | APPLIED DNA SCIENCES INC | 1.0% | $125.4k | 24,355 | – | new | |
| 22 | VANI VIVANI MEDICAL INC | 0.9% | $121.0k | 93,825 | -89% | reduced | |
| 23 | BRIACELL THERAPEUTICS CORP | 0.9% | $116.2k | 39,530 | – | new | |
| 24 | VOLCON INC | 0.8% | $110.2k | 15,835 | – | new | |
| 25 | PSYENCE BIOMEDICAL LTD | 0.8% | $108.3k | 20,328 | – | new | |
| 26 | REVIVA PHARMACEUTCLS HLDGS INC | 0.5% | $64.8k | 169,921 | – | new | |
| 27 | REVELATION BIOSCIENCES INC | 0.4% | $49.3k | 65,789 | – | new | |
| 28 | SUNCAR TECHNOLOGY GROUP INC | 0.4% | $46.4k | 18,200 | 0% | held | |
| 29 | ACXP ACURX PHARMACEUTICALS | 0.3% | $41.8k | 81,892 | -96% | reduced | |
| 30 | NUWELLIS INC | 0.3% | $32.6k | 147,961 | – | new | |
| 31 | U POWER LTD | 0.2% | $22.8k | 5,942 | -92% | reduced | |
| 32 | PMGC HOLDINGS INC | 0.1% | $11.5k | 5,307 | -86% | reduced | |
| 33 | SUNSHINE BIOPHARMA INC | 0.0% | $2.2k | 1,558 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.